
Tema Heart & Health ETF
HRTSNASDAQTemaEquity
As of Nov 16, 2026 close
- Assets (AUM)
- $53.10M
- Expense ratio
- 0.75%
- Dividend yield
- 1.22%
- Holdings
- 48
- 52-week range
- $32.59$39.92
- Volume (live)
- -
- Avg. volume (3M)
- 2.05K
HRTS ETF Holdings: Tema Heart & Health ETF
The largest positions with their portfolio weights, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 25 of 48 HRTS Holdings by Portfolio Weight
Holdings data last updated Nov 14, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 25 positions.
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Eli Lilly and Company | Stock | 12.61% |
| 2 | ![]() | Thermo Fisher Scientific Inc. | Stock | 5.40% |
| 3 | OTC:RHHBY | Roche Holding AG | Stock | 4.29% |
| 4 | ![]() | Merck & Co., Inc. | Stock | 4.16% |
| 5 | ![]() | Kodiak Sciences Inc. | Stock | 4.06% |
| 6 | ![]() | BridgeBio Pharma, Inc. | Stock | 3.72% |
| 7 | ![]() | Gilead Sciences, Inc. | Stock | 3.40% |
| 8 | ![]() | Revolution Medicines, Inc. | Stock | 3.31% |
| 9 | ![]() | Danaher Corporation | Stock | 3.11% |
| 10 | ![]() | Johnson & Johnson | Stock | 3.07% |
| 11 | ![]() | UnitedHealth Group Incorporated | Stock | 3.03% |
| 12 | ![]() | Abbott Laboratories | Stock | 2.91% |
| 13 | CPH:NOVO.B | Novo Nordisk A/S | Stock | 2.91% |
| 14 | LON:AZN | AstraZeneca PLC | Stock | 2.90% |
| 15 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 2.87% |
| 16 | SWX:NOVN | Novartis AG | Stock | 2.79% |
| 17 | ![]() | Cytokinetics, Incorporated | Stock | 2.76% |
| 18 | ![]() | Intuitive Surgical, Inc. | Stock | 2.46% |
| 19 | ![]() | McKesson Corporation | Stock | 2.39% |
| 20 | ![]() | Medtronic plc | Stock | 2.26% |
| 21 | ![]() | Stryker Corporation | Stock | 2.20% |
| 22 | ![]() | Centene Corporation | Stock | 1.98% |
| 23 | ![]() | AbbVie Inc. | Stock | 1.79% |
| 24 | ![]() | Edwards Lifesciences Corporation | Stock | 1.76% |
| 25 | TYO:4578 | Otsuka Holdings Co., Ltd. | Stock | 1.43% |
Source: Fund holdings disclosures. Last updated Nov 14, 2026. Data sources and methodology
Frequently Asked Questions About Tema Heart & Health ETF Holdings
What are the top holdings in HRTS?
In holdings data last updated Nov 14, 2026, HRTS's largest holdings are Eli Lilly and Company (LLY) at 12.61%, Thermo Fisher Scientific Inc. (TMO) at 5.40%, Roche Holding AG (OTC:RHHBY) at 4.29%, Merck & Co., Inc. (MRK) at 4.16% and Kodiak Sciences Inc. (KOD) at 4.06%. Together these 5 positions make up 30.5% of the fund. HRTS holds 48 securities in all; the holdings data lists the top 25 by weight.
How concentrated is HRTS's portfolio?
In holdings data last updated Nov 14, 2026, the 10 largest of HRTS's 48 positions make up 47.1% of assets. The largest single position is Eli Lilly and Company (LLY) at 12.61%. The top 25 listed positions add up to 83.6%, so the remaining 23 holdings share 16.4%. Its largest sector, Healthcare, is 100.0% of the portfolio.
What is HRTS's sector allocation?
In holdings data last updated Nov 14, 2026, HRTS's largest sector weights are Healthcare (100.0%), together 100.0% of the portfolio. It has exposure to 1 sector in total.
What countries does HRTS invest in?
In holdings data last updated Nov 14, 2026, 78.5% of HRTS's portfolio is invested in the United States, followed by Switzerland (7.8%), Denmark (4.3%) and the United Kingdom (2.9%). HRTS has exposure to 8 countries in total. By asset type the fund is 99.3% stocks and 0.7% cash.



















